Year Ahead

President Trump Is The Wild Card On Drug-Pricing Action In 2020

By John Wilkerson, Ariel Cohen / January 2, 2020 at 3:51 PM
The new year ushers in continued uncertainty over proposals to lower prescription drug prices, and President Donald Trump is viewed as the wildcard on whether Congress will pass major drug pricing legislation. Senate Finance Chair Chuck Grassley (R-IA) and House Democratic leaders hope that by May President Donald Trump will lean on Republicans to pass their respective drug pricing bills to make good on his campaign promise as the 2020 presidential election draws near, but election year politics might stymie...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.